SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $291,564 | +4.5% | 150,000 | 0.0% | 0.00% | – |
| Q4 2022 | $279,047 | +10.7% | 150,000 | 0.0% | 0.00% | – |
| Q3 2022 | $252,000 | -93.9% | 150,000 | -95.4% | 0.00% | -100.0% |
| Q2 2022 | $4,108,000 | -37.1% | 3,250,000 | -35.0% | 0.01% | -30.0% |
| Q1 2022 | $6,535,000 | +62.1% | 5,000,000 | +81.8% | 0.01% | +66.7% |
| Q4 2021 | $4,031,000 | -50.3% | 2,750,000 | -50.0% | 0.01% | -53.8% |
| Q3 2021 | $8,116,000 | +206.6% | 5,500,000 | +175.0% | 0.01% | +225.0% |
| Q2 2021 | $2,647,000 | +1.3% | 2,000,000 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $2,613,000 | +325.6% | 2,000,000 | +700.0% | 0.01% | +400.0% |
| Q4 2020 | $614,000 | -60.4% | 250,000 | -66.7% | 0.00% | -75.0% |
| Q3 2020 | $1,551,000 | +169.3% | 750,000 | +200.0% | 0.00% | +100.0% |
| Q2 2020 | $576,000 | -23.7% | 250,000 | -50.0% | 0.00% | -33.3% |
| Q1 2020 | $755,000 | -61.7% | 500,000 | -66.7% | 0.00% | -50.0% |
| Q3 2019 | $1,972,000 | – | 1,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DLD Asset Management, LP | 10,370,000 | $18,432,675 | 1.98% |
| Worth Venture Partners, LLC | 1,431,000 | $2,536,677 | 1.50% |
| CSS LLC/IL | 8,197,000 | $14,535,142 | 0.95% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,198,000 | $9,252,647 | 0.20% |
| Warberg Asset Management LLC | 517,000 | $911,580 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 3,889,000 | $6,893,877 | 0.16% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,765,625 | 0.05% |
| Point72 Asset Management, L.P. | 9,007,000 | $15,925,009 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,082,000 | $8,984,976 | 0.04% |
| D. E. Shaw & Co., Inc. | 11,089,000 | $19,645,113 | 0.02% |